American Well (NYSE:AMWL) Releases Earnings Results

Key Points

• American Well reported a quarterly earnings per share of ($1.24), beating the consensus estimate by $0.66.
• The company's stock price rose to $8.48 following the earnings announcement, with increased trading volume of 265,554 shares.
• Jane Street Group LLC increased its stake in American Well by 232.9% during the first quarter, highlighting growing institutional interest in the company.

American Well (NYSE:AMWL - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($1.24) earnings per share for the quarter, topping the consensus estimate of ($1.84) by $0.60, Zacks reports. The company had revenue of $70.90 million for the quarter, compared to analyst estimates of $63.87 million. American Well had a negative return on equity of 48.36% and a negative net margin of 59.13%. American Well updated its Q3 2025 guidance to EPS and its FY 2025 guidance to EPS.

American Well Price Performance

NYSE:AMWL opened at $8.48 on Wednesday. The business's 50-day simple moving average is $7.69 and its 200-day simple moving average is $8.31. American Well has a fifty-two week low of $6.09 and a fifty-two week high of $12.95. The stock has a market capitalization of $132.44 million, a PE ratio of -0.83 and a beta of 1.28.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Needham & Company LLC reiterated a "hold" rating on shares of American Well in a research report on Friday, May 2nd. Piper Sandler restated a "neutral" rating and issued a $8.00 target price (down previously from $10.00) on shares of American Well in a research note on Friday, May 23rd. Stifel Nicolaus dropped their target price on shares of American Well from $10.00 to $8.00 and set a "hold" rating for the company in a research report on Friday, May 2nd. UBS Group cut their price target on shares of American Well from $12.00 to $9.00 and set a "neutral" rating for the company in a report on Thursday, May 8th. Finally, Truist Financial decreased their price objective on shares of American Well from $12.00 to $7.50 and set a "hold" rating on the stock in a research note on Thursday, April 10th. Six research analysts have rated the stock with a hold rating and one has given a buy rating to the stock. According to MarketBeat.com, the stock has a consensus rating of "Hold" and a consensus price target of $9.67.

Insider Buying and Selling

In related news, insider Phyllis Gotlib sold 4,958 shares of the company's stock in a transaction on Tuesday, July 1st. The shares were sold at an average price of $8.63, for a total value of $42,787.54. Following the completion of the transaction, the insider directly owned 136,891 shares of the company's stock, valued at approximately $1,181,369.33. This represents a 3.50% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. In the last 90 days, insiders have sold 10,184 shares of company stock worth $78,000. Company insiders own 12.80% of the company's stock.

Institutional Investors Weigh In On American Well

A hedge fund recently raised its stake in American Well stock. Jane Street Group LLC lifted its holdings in shares of American Well Corporation (NYSE:AMWL - Free Report) by 232.9% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 64,112 shares of the company's stock after acquiring an additional 44,852 shares during the quarter. Jane Street Group LLC owned approximately 0.41% of American Well worth $505,000 as of its most recent SEC filing. Hedge funds and other institutional investors own 56.05% of the company's stock.

About American Well

American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.